# A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.

> clinical trial · VERIFIED · 2026-07-01

Status: ACTIVE_NOT_RECRUITING · Sponsor: Genentech, Inc. · Condition: Melanoma

- Company: Genentech, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04835805

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.